San Diego-based Viking Therapeutics marked alone as a significant competitor inside the weight loss drug marketplace in February soon after revealing promising info from the mid-phase demo of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when offered like a weekly injection As well as in March the com